Mina Shenouda

CLIN ASO PROF

MD-MEDICINE

GRANTS

  • GRANT
    A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cance
    Incyte Corporation9 Jul 2026 - 8 Jul 2031
    Active